Risk of recurrent venous thomboembolism--expanding the frontier.
Prins
Martin H
MH
Department of Clinical Epidemiology and Medical Technology Assessment, Academic Hospital Maastricht, University of Maastricht, The Netherlands. mh.prins@epid.unimaas.nl
Marchiori
Antonio
A
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D005544:Forecasting; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D015994:Incidence; D011446:Prospective Studies; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012306:Risk; D012307:Risk Factors; D019851:Thrombophilia / Q000453:epidemiology / Q000235:genetics; D020246:Venous Thrombosis / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control
D000925:Anticoagulants